Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma
Clinical trial NCT02451111 · TERMINATED
Trial details
- NCT number
- NCT02451111
- Sponsor
- Swiss Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-06
- Primary completion
- 2022-12-01
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.